Literature DB >> 34214472

Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthy.

Vivien Béziat1, Franck Rapaport2, Jiafen Hu3, Matthias Titeux4, Mathilde Bonnet des Claustres4, Mathieu Bourgey5, Heather Griffin6, Élise Bandet4, Cindy S Ma7, Roya Sherkat8, Hassan Rokni-Zadeh9, David M Louis10, Majid Changi-Ashtiani11, Ottavia M Delmonte12, Toshiaki Fukushima13, Tanwir Habib14, Andrea Guennoun14, Taushif Khan14, Noemi Bender15, Mahbuba Rahman14, Frédégonde About4, Rui Yang2, Geetha Rao7, Claire Rouzaud16, Jingwei Li3, Debra Shearer3, Karla Balogh3, Fatima Al Ali14, Manar Ata14, Soroosh Dabiri17, Mana Momenilandi18, Justine Nammour4, Marie-Alexandra Alyanakian19, Marianne Leruez-Ville19, David Guenat20, Marie Materna4, Léa Marcot4, Natasha Vladikine4, Christine Soret20, Hassan Vahidnezhad21, Leila Youssefian21, Amir Hossein Saeidian21, Jouni Uitto21, Émilie Catherinot22, Shadi Sadat Navabi23, Mohammed Zarhrate4, David T Woodley24, Mohamed Jeljeli25, Thomas Abraham3, Serkan Belkaya2, Lazaro Lorenzo4, Jérémie Rosain16, Mousa Bayat17, Fanny Lanternier16, Olivier Lortholary16, Faramarz Zakavi26, Philippe Gros27, Gérard Orth28, Laurent Abel29, Jean-Luc Prétet20, Sylvie Fraitag19, Emmanuelle Jouanguy29, Mark M Davis30, Stuart G Tangye7, Luigi D Notarangelo12, Nico Marr14, Tim Waterboer15, David Langlais27, John Doorbar6, Alain Hovnanian16, Neil Christensen3, Xavier Bossuyt18, Mohammad Shahrooei31, Jean-Laurent Casanova32.   

Abstract

We study a patient with the human papilloma virus (HPV)-2-driven "tree-man" phenotype and two relatives with unusually severe HPV4-driven warts. The giant horns form an HPV-2-driven multifocal benign epithelial tumor overexpressing viral oncogenes in the epidermis basal layer. The patients are unexpectedly homozygous for a private CD28 variant. They have no detectable CD28 on their T cells, with the exception of a small contingent of revertant memory CD4+ T cells. T cell development is barely affected, and T cells respond to CD3 and CD2, but not CD28, costimulation. Although the patients do not display HPV-2- and HPV-4-reactive CD4+ T cells in vitro, they make antibodies specific for both viruses in vivo. CD28-deficient mice are susceptible to cutaneous infections with the mouse papillomavirus MmuPV1. The control of HPV-2 and HPV-4 in keratinocytes is dependent on the T cell CD28 co-activation pathway. Surprisingly, human CD28-dependent T cell responses are largely redundant for protective immunity.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD28; HPV; T cell; cutaneous horn; immunodeficiency; oncogene; papillomavirus; somatic reversion; tree man syndrome; wart

Mesh:

Substances:

Year:  2021        PMID: 34214472      PMCID: PMC8329841          DOI: 10.1016/j.cell.2021.06.004

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   66.850


  117 in total

1.  Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells.

Authors:  Qizhi Tang; Kammi J Henriksen; Elisa K Boden; Aaron J Tooley; Jianqin Ye; Sumit K Subudhi; Xin X Zheng; Terry B Strom; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

2.  CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.

Authors:  Xuguang Tai; Michelle Cowan; Lionel Feigenbaum; Alfred Singer
Journal:  Nat Immunol       Date:  2005-01-09       Impact factor: 25.606

3.  Publisher Correction: PhIP-Seq characterization of serum antibodies using oligonucleotide-encoded peptidomes.

Authors:  Divya Mohan; Daniel L Wansley; Brandon M Sie; Muhammad S Noon; Alan N Baer; Uri Laserson; H Benjamin Larman
Journal:  Nat Protoc       Date:  2019-08       Impact factor: 13.491

4.  In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis.

Authors:  Elizabeth Gray; Mark R Pett; Dawn Ward; David M Winder; Margaret A Stanley; Ian Roberts; Cinzia G Scarpini; Nicholas Coleman
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

5.  Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis.

Authors:  Nicolas Ramoz; Luis-Alfredo Rueda; Bakar Bouadjar; Luz-Stella Montoya; Gérard Orth; Michel Favre
Journal:  Nat Genet       Date:  2002-11-11       Impact factor: 38.330

6.  Diseases associated with human papillomavirus infection.

Authors:  Heather A Cubie
Journal:  Virology       Date:  2013-08-09       Impact factor: 3.616

7.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

8.  Keratinocytes costimulate naive human T cells via CD2: a potential target to prevent the development of proinflammatory Th1 cells in the skin.

Authors:  Christian Orlik; Daniel Deibel; Johanna Küblbeck; Emre Balta; Sabina Ganskih; Jüri Habicht; Beate Niesler; Jutta Schröder-Braunstein; Knut Schäkel; Guido Wabnitz; Yvonne Samstag
Journal:  Cell Mol Immunol       Date:  2019-07-19       Impact factor: 11.530

9.  Profiling HPV-16-specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patients.

Authors:  Kunal H Bhatt; Michelle A Neller; Sriganesh Srihari; Pauline Crooks; Lea Lekieffre; Blake T Aftab; Howard Liu; Corey Smith; Liz Kenny; Sandro Porceddu; Rajiv Khanna
Journal:  J Exp Med       Date:  2020-10-05       Impact factor: 14.307

10.  Immunologic Control of Mus musculus Papillomavirus Type 1.

Authors:  Joshua W Wang; Rosie Jiang; Shiwen Peng; Yung-Nien Chang; Chien-Fu Hung; Richard B S Roden
Journal:  PLoS Pathog       Date:  2015-10-23       Impact factor: 6.823

View more
  21 in total

Review 1.  Human genetic and immunological dissection of papillomavirus-driven diseases: new insights into their pathogenesis.

Authors:  Vivien Béziat; Jean-Laurent Casanova; Emmanuelle Jouanguy
Journal:  Curr Opin Virol       Date:  2021-09-21       Impact factor: 7.090

Review 2.  Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, "I Am like a Box of Complexity, You Never Know What You Are Gonna Get".

Authors:  Ehsan Soleymaninejadian; Paola Zelini; Irene Cassaniti; Fausto Baldanti; Mattia Dominoni; Andrea Gritti; Barbara Gardella
Journal:  Vaccines (Basel)       Date:  2022-05-06

3.  Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee.

Authors:  Stuart G Tangye; Waleed Al-Herz; Aziz Bousfiha; Charlotte Cunningham-Rundles; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Eric Oksenhendler; Capucine Picard; Anne Puel; Jennifer Puck; Mikko R J Seppänen; Raz Somech; Helen C Su; Kathleen E Sullivan; Troy R Torgerson; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2022-06-24       Impact factor: 8.542

Review 4.  Consideration of underlying immunodeficiency in refractory or recalcitrant warts: A review of the literature.

Authors:  J Zampella; B Cohen
Journal:  Skin Health Dis       Date:  2022-02-09

5.  Recalcitrant Warts, Epidermodysplasia Verruciformis, and the Tree-Man Syndrome: Phenotypic Spectrum of Cutaneous Human Papillomavirus Infections at the Intersection of Genetic Variability of Viral and Human Genomes.

Authors:  Jouni Uitto; Amir Hossein Saeidian; Leila Youssefian; Zahra Saffarian; Jean-Laurent Casanova; Vivien Béziat; Emmanuelle Jouanguy; Hassan Vahidnezhad
Journal:  J Invest Dermatol       Date:  2021-11-27       Impact factor: 7.590

Review 6.  Mechanisms of viral inflammation and disease in humans.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Science       Date:  2021-11-25       Impact factor: 63.714

Review 7.  Human papillomaviruses: diversity, infection and host interactions.

Authors:  Alison A McBride
Journal:  Nat Rev Microbiol       Date:  2021-09-14       Impact factor: 60.633

8.  Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses.

Authors:  Karl L Banta; Xiaozheng Xu; Avantika S Chitre; Amelia Au-Yeung; Chikara Takahashi; William E O'Gorman; Thomas D Wu; Stephanie Mittman; Rafael Cubas; Laetitia Comps-Agrar; Amit Fulzele; Eric J Bennett; Jane L Grogan; Enfu Hui; Eugene Y Chiang; Ira Mellman
Journal:  Immunity       Date:  2022-03-08       Impact factor: 43.474

9.  Recalcitrant Cutaneous Warts in a Family with Inherited ICOS Deficiency.

Authors:  Leila Youssefian; Amir Hossein Saeidian; Ali Reza Tavasoli; Elnaz Kalamati; Karim Naghipoor; Amir Hozhabrpour; Mehrnaz Mesdaghi; Zahra Saffarian; Hamidreza Mahmoudi; Mohammad Nabavi; Sima Shokri; Sirous Zeinali; Vivien Béziat; Jean-Laurent Casanova; Emmanuelle Jouanguy; Jouni Uitto; Hassan Vahidnezhad
Journal:  J Invest Dermatol       Date:  2022-03-08       Impact factor: 7.590

Review 10.  Human inborn errors of immunity to oncogenic viruses.

Authors:  Vivien Béziat; Emmanuelle Jouanguy
Journal:  Curr Opin Immunol       Date:  2021-08-05       Impact factor: 7.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.